Use of a Predictive Analytics Algorithm to Optimize Weaning of Inotropes Following Pediatric Cardiac Surgery
NCT04600700 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2021-10-08
Summary
The objective of this study is to determine the effectiveness of a real time continuous risk analytics algorithm in the successful de-escalation of vasoactive and inotropic support in pediatric patients following cardiac surgery.
Conditions
- Congenital Heart Disease
Interventions
- DEVICE
-
Clinical Decision support system (CDSS) for inotrope weaning
A Clinical Decision Support System informed by 6-hour rolling average IDO2, will be utilized during the intervention phase of the study. The CDSS tool will be introduced in a stepped-wedge pattern. Randomization will occur by center, with time of introduction being staggered, with each center ultimately receiving the CDSS intervention. Teams in the CICU make rounds twice per day. During each of the rounds (AM and PM), the team will refer to the CDSS and the 6-hour average IDO2 (as reported on the T3 platform at the bedside computer). The clinical team will consider the CDSS in decision making around inotrope weans. If the decision is made to not utilize IDO2, the bedside clinician will complete a brief survey with rationale.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH - lead OTHER
Principal Investigators
-
Joshua W Salvin, MD · Boston Children's Hospital
Eligibility
- Min Age
- 1 Day
- Max Age
- 365 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-01
- Primary Completion
- 2022-12-31
- Completion
- 2023-03-01
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Levosimendan in Congenital Cardiac Surgery
NCT00695929 ·Status: COMPLETED ·Phase: NA
-
Adrenal Responsiveness During the Perioperative Period in Children Undergoing Congenital Cardiac Surgery
NCT01839812 ·Status: COMPLETED ·Phase: PHASE1
-
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
NCT04217421 ·Status: RECRUITING ·Phase: PHASE3
-
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
NCT03229538 ·Status: COMPLETED ·Phase: PHASE3
-
Two Inodilators Postsurgery in Neonates
NCT01576094 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
The Pharmacology and Hemodynamics of Dexmedetomidine in Children With Congenital Heart Disease
NCT00480740 ·Status: COMPLETED ·Phase: PHASE3
-
Relationship of Brain Natriuretic Peptide (BNP) Levels to Cardiac Diagnosis, Operation Performed, Post-operative Course and Outcome
NCT00238810 ·Status: COMPLETED
-
Citrulline for Children Undergoing Cardiopulmonary Bypass Surgery
NCT00201214 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac Surgery
NCT01245595 ·Status: COMPLETED ·Phase: NA
-
Study of Possible Brain Hormone Problems After Open Heart Surgery in Infants
NCT00850720 ·Status: TERMINATED
-
Down Syndrome Autonomic Nervous System Induction Bradycardia
NCT05120531 ·Status: COMPLETED
-
The Role of Dexmedetomidine As Myocardial Protection In Pediatric Cyanotic Congenital Heart Disease Undergoing Open Cardiac Surgery Using Cardiopulmonary Bypass Machine: A Preliminary Study
NCT05300802 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cardiaplication: A Novel Antireflux Operation
NCT02060500 ·Status: COMPLETED ·Phase: NA
-
Precision Medicine in the CICU: Identifying Proteomic Biomarkers
NCT06642662 ·Status: ENROLLING_BY_INVITATION
-
Ventricular Remodelling and Metabolomics in Pediatric Cardiomyopathies (PROGRESS-OMICS)
NCT04670731 ·Status: UNKNOWN
-
Hypertonic Saline Dextran in Pediatric Cardiac Surgery
NCT00199771 ·Status: COMPLETED ·Phase: PHASE2
-
Use of the Cardioprotectant Dexrazoxane During Congenital Heart Surgery
NCT04997291 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects
NCT05253209 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Drug Therapy for Pediatric Heart Failure
NCT06039540 ·Status: UNKNOWN
-
The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
NCT00004854 ·Status: COMPLETED ·Phase: PHASE1
-
Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation
NCT04151004 ·Status: COMPLETED ·Phase: NA
-
Pediatric Cardiomyopathy Mutation Analysis
NCT02432092 ·Status: RECRUITING
-
Effects of Pulmonary Vasodilation Upon VA Coupling in Fontan Patients
NCT01607983 ·Status: WITHDRAWN ·Phase: PHASE3
-
Early Use of Vasopressin in Post-Fontan Management
NCT03088345 ·Status: COMPLETED ·Phase: PHASE2/PHASE3